2020 Outcomes - BSW Heart and Vascular Hospital fiscal year 2020 | Page 51

• Ascending aortic aneurysms and dissections
• Atrial septal defects ( ASD )
• Heart valve disease – abnormalities , valve insufficiency , regurgitation , stenosis and damaged artificial valves
• Hypertrophic cardiomyopathy
• Left atrial appendage thrombus
• Patent foramen ovale ( PFO )
• Prosthetic valve paravalvular leaks
• Ventricular septal defects ( VSD )
• Atrial septal defect ( ASD ) closure
• Left atrial appendage occlusion ( LAAO )
• Minimally invasive surgical repair of structural heart defects
• Minimally invasive tricuspid valve repair
• Patent foramen ovale ( PFO ) catheter repair
• Port access minimally invasive aortic valve replacement
• Robotic cardiothoracic surgery
• Surgical repair of ascending aortic aneurysms and dissections
• Transcatheter aortic valve replacement ( TAVR )
• Transcatheter mitral valve repair – minimally invasive ( TMVR )
51

STRUCTURAL HEART DISEASE PROGRAM

Baylor Scott & White Heart and Vascular Hospital – Fort Worth is proud to offer what was Tarrant County ’ s first comprehensive Structural Heart Disease Program . A multidisciplinary team of experienced cardiologists , cardiothoracic surgeons , interventional cardiologists , electrophysiologists and imaging specialists on our medical staff , along with our specialized nurses , combine their expertise with advanced technologies to treat a variety of patient conditions . The medical director of the Structural Heart Disease Program is George S . Kammar , MD , FACC .
Conditions treated :

• Ascending aortic aneurysms and dissections

• Atrial septal defects ( ASD )

• Heart valve disease – abnormalities , valve insufficiency , regurgitation , stenosis and damaged artificial valves

• Hypertrophic cardiomyopathy

• Left atrial appendage thrombus

• Patent foramen ovale ( PFO )

• Prosthetic valve paravalvular leaks

• Ventricular septal defects ( VSD )

Specialized treatments :

• Atrial septal defect ( ASD ) closure

• Left atrial appendage occlusion ( LAAO )

• Minimally invasive surgical repair of structural heart defects

• Minimally invasive tricuspid valve repair

• Patent foramen ovale ( PFO ) catheter repair

• Port access minimally invasive aortic valve replacement

• Robotic cardiothoracic surgery

• Surgical repair of ascending aortic aneurysms and dissections

• Transcatheter aortic valve replacement ( TAVR )

• Transcatheter mitral valve repair – minimally invasive ( TMVR )

Interventional cardiology clinical trials in fiscal year 2020 included PRECISION GRX Registry : a multicenter post-market registry for the evaluation of the CorPath ® GRX system effectiveness in percutaneous coronary interventions . The principal investigator is Srinivasa Potluri , MD , and Fort Worth campus and sub-investigator is Farhan Ali , MD .
Total number of TAVR implants ( Oct . 2017 –
Jun . 30 , 2020 ):

> 200

Total transcatheter mitral valve repair ( since beginning of
program in FY18 ):

44

Median length of stay
( FY20 ):

1 day

Post-minimally invasive valve replacement patients discharged home with no additional
care required ( FY20 ):

> 80 %

Baylor Scott & White Heart and Vascular Hospital – Fort Worth Structural Heart Disease Program